Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors

被引:111
作者
Donevan, SD
McCabe, RT
机构
[1] Univ Utah, Dept Neurol, Salt Lake City, UT USA
[2] Cognetix Inc, Salt Lake City, UT USA
关键词
D O I
10.1124/mol.58.3.614
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Conantokin G (Con G) is a 17-amino-acid peptide antagonist of N-methyl-D-aspartate (NMDA) receptors isolated from the venom of the marine cone snail, Conus geographus. The mechanism of action of Con G has not been well defined; both competitive and noncompetitive interactions with the NMDA-binding site have been proposed. In this study the mechanism of action and subunit selectivity of Con G was examined in whole-cell voltage-clamp recordings from cultured neurons and in two electrode voltage-clamp recordings from Xenopus oocytes expressing recombinant NMDA receptors. Con G was a potent and selective antagonist of NMDA-evoked currents in murine cortical neurons (IC50 = 480 nM). The slow onset of Con G block could be prevented by coapplication with high concentrations of NMDA or of the competitive antagonist (RS)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid. Furthermore, in oocytes expressing NR1a/NR2B receptors, Con G produced a rightward shift in the concentration-response curve for NMDA, providing support for a competitive interaction with the NMDA-binding site. Con G produced an apparent noncompetitive shift in the concentration-response curve for spermine potentiation of NMDA responses, but this was due to spermine-induced enhancement of Con G block. Spermine produced a similar enhancement of DL-2-amino-S-phosphopentanoic acid block. Finally, Con G selectively blocked NMDA receptors containing the NR2B subunit. These results demonstrate that Con G is a subunit-specific competitive antagonist of NMDA receptors. The unique subunit selectivity profile of Con G may explain its favorable in vivo profile compared with nonselective NMDA antagonists.
引用
收藏
页码:614 / 623
页数:10
相关论文
共 40 条
[1]  
ARMSTRONG H, 1999, EPILEPSIA, V36, P39
[2]  
BARON BM, 1992, J PHARMACOL EXP THER, V262, P947
[3]   N-METHYL-D-ASPARTATE RECEPTORS ARE CLUSTERED AND IMMOBILIZED ON DENDRITES OF LIVING CORTICAL-NEURONS [J].
BENKE, TA ;
JONES, OT ;
COLLINGRIDGE, GL ;
ANGELIDES, KJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7819-7823
[4]   Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits [J].
Blahos, J ;
Wenthold, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15669-15674
[5]  
BULLER AL, 1994, J NEUROSCI, V14, P5471
[6]   Pharmacological heterogeneity of NMDA receptors: Characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes [J].
Buller, AL ;
Monaghan, DT .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 320 (01) :87-94
[7]   RELEASE OF SPERMIDINE FROM THE RAT CORTEX FOLLOWING PERMANENT MIDDLE CEREBRAL-ARTERY OCCLUSION [J].
CARTER, C ;
POIGNET, H ;
CARBONI, S ;
FAGE, D ;
VOLTZ, C ;
SCATTON, B .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (02) :129-140
[8]  
Chazot PL, 1997, J NEUROCHEM, V69, P2138
[9]  
CHAZOT PL, 1994, J BIOL CHEM, V269, P24403
[10]  
Dingledine R, 1999, PHARMACOL REV, V51, P7